Significantly improved ADHD core symptoms, such as inattention, impulsivity, and hyperactivity, in adolescents with ADHD

Mean Total ADHD Rating Scale Scores as Rated by Investigators (n=175)¹

Adapted from Wilens et al, 2006.

*A multisite, double-blind study in 177 adolescents with ADHD, aged 13 to 18 years. Patients received CONCERTA^® 18-72 mg or placebo.

CONCERTA^® significantly reduced symptoms in adolescents with ADHD to a level comparable to adolescents without ADHD, such as†^1-2

Reduced forgetfulness-for homework due dates
Fewer careless mistakes-for taking tests
Less distractibility-for class

References: 1. Wilens TE, McBurnett K, Bukstein O, et al. Multisite controlled study of OROS® methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006;160:82-90. 2. Data on file (CON008), McNeil Pediatrics.